BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29044507)

  • 1. TIEG and estrogen modulate SOST expression in the murine skeleton.
    Subramaniam M; Pitel KS; Bruinsma ES; Monroe DG; Hawse JR
    J Cell Physiol; 2018 Apr; 233(4):3540-3551. PubMed ID: 29044507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
    Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
    J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin antibody treatment rescues the osteopenic bone phenotype of TGFβ inducible early gene-1 knockout female mice.
    Gingery A; Subramaniam M; Pitel KS; Li X; Ke HZ; Turner RT; Iwaniec UT; Hawse JR
    J Cell Physiol; 2020 Jul; 235(7-8):5679-5688. PubMed ID: 31975377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture.
    Bensamoun SF; Hawse JR; Subramaniam M; Ilharreborde B; Bassillais A; Benhamou CL; Fraser DG; Oursler MJ; Amadio PC; An KN; Spelsberg TC
    Bone; 2006 Dec; 39(6):1244-51. PubMed ID: 16876494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
    Li F; Cain JD; Tombran-Tink J; Niyibizi C
    J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mef2c deletion in osteocytes results in increased bone mass.
    Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M
    J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium.
    Ryan ZC; Ketha H; McNulty MS; McGee-Lawrence M; Craig TA; Grande JP; Westendorf JJ; Singh RJ; Kumar R
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6199-204. PubMed ID: 23530237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
    Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
    J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Effect of 17β-estradiol on Osteoporosis in Ovariectomized Rats Accompanied with Unilateral Disuse in the Early Phase.
    Sun X; Liang J; Wang C; Cao S; Hu Y; Xu X
    Int J Med Sci; 2015; 12(5):423-31. PubMed ID: 26078702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
    Li C; Wang W; Xie L; Luo X; Cao X; Wan M
    Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
    Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
    J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice.
    Doolittle ML; Saul D; Kaur J; Rowsey JL; Eckhardt B; Vos S; Grain S; Kroupova K; Ruan M; Weivoda M; Oursler MJ; Farr JN; Monroe DG; Khosla S
    J Bone Miner Res; 2022 Sep; 37(9):1750-1760. PubMed ID: 35789113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
    Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
    Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.
    Wein MN; Spatz J; Nishimori S; Doench J; Root D; Babij P; Nagano K; Baron R; Brooks D; Bouxsein M; Pajevic PD; Kronenberg HM
    J Bone Miner Res; 2015 Mar; 30(3):400-11. PubMed ID: 25271055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton.
    Hawse JR; Pitel KS; Cicek M; Philbrick KA; Gingery A; Peters KD; Syed FA; Ingle JN; Suman VJ; Iwaniec UT; Turner RT; Spelsberg TC; Subramaniam M
    J Bone Miner Res; 2014; 29(5):1206-16. PubMed ID: 24190163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
    Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
    Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.